Juvelook vs Sculptra at a glance
| Juvelook | Sculptra | |
|---|---|---|
| Material | PDLLA microspheres (42.5 mg) with non-cross-linked hyaluronic acid (7.5 mg) | Poly-L-lactic acid (150 mg) with carboxymethylcellulose and mannitol |
| Particles | Round, porous, about 30 µm | Flat, irregular, about 50 µm |
| Stronger version | Juvelook Volume (Lenisna), 170 mg PDLLA with 30 mg hyaluronic acid | One strength, diluted with 5 to 8 ml |
| US approval | None | Facial fat loss in HIV (2004), nasolabial folds and wrinkles (2009), cheek wrinkles (2023) |
| Eye area on the label | Not named | Not studied, with more lumps reported (US), and not to be injected (Australia) |
| Evidence grade, under-eye | C | C, off-label and advised against on the label |
| Evidence grade, cheeks and temples | B (Juvelook Volume vs Sculptra, nasolabial folds) | A for cheeks, B for temples |
| 2026 Singapore price | S$388 half vial, S$688 full vial, Juvelook Volume S$988 to 1,188 | About S$1,000 to 1,300 a vial (two clinics list S$3,000) |
| Usual course | 3 sessions, 4 weeks apart | 2 to 4 sessions, at least 4 weeks apart |
| How long it lasts | Up to 6 months in under-eye studies | Up to 24 to 25 months in cheek and fold trials |
| Main risks | Nodules if placed too superficially, rare vascular blockage | Nodules and granulomas, more often around the eyes and mouth, rare vascular blockage |
How Juvelook and Sculptra stimulate collagen
- Sculptra The vial of PLLA powder is reconstituted with 5 to 8 ml of sterile water and injected into the deep dermis, the fat beneath the skin or onto the bone. As the particles break down over 18 months or longer, they provoke a controlled foreign-body reaction in which fibroblasts lay down new collagen around them. The water is absorbed within days, whereas the collagen result develops over 2 to 3 months. Because the final volume cannot be judged on the day of injection, the label warns against overcorrection. Massage of the treated area five times a day for five days is advised to spread the particles evenly.
- Juvelook The PDLLA microspheres are smaller, rounder and porous, are absorbed faster than PLLA particles and stimulate collagen through the same foreign-body reaction. The small dose of hyaluronic acid provides some immediate hydration while the collagen response develops. Standard Juvelook is injected in thin layers under the eyes, whereas Juvelook Volume (Lenisna) is the stronger formulation for deeper volume loss.
Juvelook vs Sculptra for sunken eyes and tear troughs
- Juvelook under the eyes, Grade C In a prospective study of 15 women, led from Singapore, three monthly sessions of about 0.4 ml per eye improved tear-trough appearance and lower-lid skin quality. The study had no control group, and both authors have received speaker fees from the manufacturer. A small Korean case series reported improvement maintained at 6 months.
- Sculptra under the eyes, off-label In a retrospective review of 28 patients, double-diluted PLLA was placed below the lower-lid ligament, a deeper plane that keeps the particles away from the thin lid skin. Satisfaction averaged 3.4 out of 5, and one patient developed a palpable lump. Earlier reports describe visible under-eye granulomas that required surgical excision, and a 2022 review of delayed tear-trough complications linked PLLA to lumps and nodules more often than other fillers.
- Juvelook vs Sculptra under the eyes, Grade D No study has compared the two products in the under-eye area.
Hyaluronic acid filler remains the first-line treatment for a tear-trough hollow (Grade A), because its effect is immediate and it can be dissolved with hyaluronidase if a lump or vascular problem develops. Filler options are compared on Sunken eyes treatment in Singapore.
Juvelook vs Sculptra for temples, cheeks and facial hollows
- Head to head In a randomised split-face trial of 33 Korean patients, Juvelook Volume injected into one nasolabial fold and Sculptra into the other produced comparable improvement at 24 weeks after three sessions. One Juvelook Volume side developed moderate swelling and tenderness. The trial was funded by Juvelook’s manufacturer.
- Sculptra on the cheeks, Grade A In the US approval trial for cheek wrinkles, 71.6% of treated patients were responders at 12 months, compared with 26.1% of untreated controls, and the effect was maintained to 24 months. A randomised trial in nasolabial folds found benefit for up to 25 months.
- PLLA in the temples, Grade B A randomised trial of 24 patients comparing two Sculptra injection techniques rated every patient at least “improved” at 38 weeks. A larger controlled trial of 174 patients showed temple filling maintained to 12 months, but it used a different PLLA brand.
A sunken appearance around the eyes often results from hollow temples and flattened upper cheeks in addition to the tear trough, because volume lost from these areas removes the support around the orbit and deepens its shadow. The evidence for each product therefore supports a collagen stimulator for the temples and cheeks, and filler or a skin booster for the tear trough itself.
Juvelook vs Sculptra price in Singapore (2026)
| Product | Per vial or session | Usual course | Course total |
|---|---|---|---|
| Juvelook | S$388 half vial, S$688 full vial (up to S$1,200 a session) | 3 sessions | S$1,200 to 3,600 |
| Juvelook Volume (Lenisna) | S$988 to 1,188 a vial | 2 to 4 vials | S$2,000 to 4,800 |
| Sculptra (PLLA) | S$988 to 1,308 a vial, S$3,000 at two clinics (vial or course not stated) | 2 to 4 vials | S$2,000 to 5,200 at per-vial prices |
Several Singapore clinics list Sculptra only as a “PLLA collagen stimulator” without naming the brand, and a second PLLA product has been registered in Singapore since January 2026. Prices between clinics can therefore be compared only on a quote that names the product and the number of vials.
Juvelook vs Sculptra side effects and nodule risk
- Nodules and granulomas Both products can form firm lumps under the skin. Nodules form where particles clump together, typically after superficial placement or uneven dilution, whereas granulomas are a delayed inflammatory reaction to the particles. For Sculptra, a US post-approval study recorded papules or nodules in 28% of patients, more often with larger volumes and in the marionette lines. Around the eyes, case series report granulomas appearing months after injection, some of which required surgery. For Juvelook, case reports describe tear-trough nodules that resolved with radiofrequency treatment and lower-lid granulomas that required surgical removal.
- No dissolver Unlike hyaluronic acid filler, neither product can be dissolved with an enzyme, so persistent lumps are managed with steroid injection, energy-based treatment or surgical removal.
- Vascular blockage Vision loss occurs when injected material enters a facial artery and travels back into the artery that supplies the eye. A 2026 review counted two cases of vision loss after PLLA and one after PDLLA with hyaluronic acid, and a separate report describes severe vision loss after periorbital PLLA. A Singapore case report describes vision loss and strokes after PDLLA was injected into the nasolabial folds and under the eyes.
Which lasts longer, Juvelook or Sculptra?
Sculptra has the longer documented effect, up to 24 to 25 months in cheek and nasolabial-fold trials. Juvelook’s under-eye studies follow patients for 6 months, and the head-to-head trial in the nasolabial folds ended at 24 weeks. Because PDLLA is absorbed faster than PLLA, a shorter duration is expected, although this has not been measured head to head.
Juvelook vs Sculptra, which to choose for each area
- Thin skin or a mild hollow under the eyes Juvelook, or Rejuran I where the lowest lump risk is the priority, because polynucleotides contain no particles that can clump (compared on Juvelook vs Rejuran).
- A definite tear-trough groove Hyaluronic acid filler, which fills the groove immediately and can be dissolved.
- Hollow temples or flat upper cheeks around a sunken eye Sculptra, or Juvelook Volume.
- Thin skin plus hydration across the face The options are compared on Juvelook vs Profhilo.
The causes of sunken eyes are explained in the Sunken-looking eyes guide.
Frequently asked questions about Juvelook and Sculptra
Can Sculptra be used under the eyes?
Some doctors inject diluted Sculptra below the under-eye ligament, but this use is off-label. The US label states that periorbital use has not been studied and is associated with more reported lumps, and the Australian instructions state that it should not be injected there.
Is Juvelook or Sculptra better for sunken eyes?
For the under-eye area itself, Juvelook has small supporting studies and is injected in thin layers, although hyaluronic acid filler remains first-line for a defined groove. Sculptra is suited to the temples and cheeks around a sunken eye.
What is the difference between Juvelook and Sculptra?
Both are polylactic acid collagen stimulators. Sculptra is poly-L-lactic acid with larger, flat particles and an effect lasting up to about two years. Juvelook is poly-D,L-lactic acid with smaller, round particles and a little hyaluronic acid.
Do Juvelook or Sculptra cause lumps?
Both can cause nodules or granulomas, more often when placed too superficially or around the eyes and mouth. Unlike hyaluronic acid filler, neither can be dissolved.
How much does Sculptra cost in Singapore?
Where clinics publish per-vial prices, Sculptra costs about S$1,000 to 1,300 a vial in 2026, and a course usually uses 2 to 4 vials. Juvelook costs S$388 for a half vial and S$688 for a full vial.
General information, not medical advice. A registered medical practitioner should be consulted before any treatment. Dark Eye Circles Singapore does not sell treatments.
Sources and price references (checked 8 October 2026)
- Young SM, Lau EKH. Hybrid Biostimulator and Hyaluronic Acid Injectable for Tear Trough Rejuvenation. Aesthetic Plast Surg. 2026;50(13):5337–5343. doi:10.1007/s00266-026-05817-z (PMID 42098500) — Prospective cohort, 15 women, Juvelook (PDLLA-HA 50 mg), 3 sessions; no control group; authors report VAIM speaker honoraria https://doi.org/10.1007/s00266-026-05817-z
- Wan J, et al. Evaluating Poly-D,L-Lactic Acid for Lower Eyelid Rejuvenation: Efficacy and Safety. J Cosmet Dermatol. 2025;24(3):e70058. doi:10.1111/jocd.70058 (PMID 40017393) — Small case series, Juvelook for tear trough, 6-month follow-up https://doi.org/10.1111/jocd.70058
- Park JY, et al. A Split Face Study Comparing the Effect of a PDLLA Based Product and PLLA on the Nasolabial Fold (NLF). Skin Res Technol. 2026;32(1):e70324. doi:10.1111/srt.70324 (PMID 41532837) — Randomised split-face, 33 subjects, Juvelook Volume vs PLLA, nasolabial folds, non-inferior at 24 weeks https://doi.org/10.1111/srt.70324
- Seo SB, Wan J, Yi KH. Energy-Based Device Management of Nodular Reaction Following Poly-D, L-Lactic Acid Injection for Tear Trough Rejuvenation. J Cosmet Dermatol. 2025;24(1):e16575. doi:10.1111/jocd.16575 (PMID 39283001) — Case report, nodules 3 weeks after Juvelook in the tear trough https://doi.org/10.1111/jocd.16575
- Garlaschi A, et al. Complex Surgical Management of PDLLA-Induced Lower Eyelid Granulomas. J Craniofac Surg. 2026. doi:10.1097/SCS.0000000000012811 (PMID 42043184) — Case report, lower-eyelid granulomas after PDLLA requiring surgery https://doi.org/10.1097/SCS.0000000000012811
- Tan YJ, Sugianto N, Li Y. Multifocal strokes and vision loss from PDLLA filler injections. J Stroke Cerebrovasc Dis. 2024;33(3):107556. doi:10.1016/j.jstrokecerebrovasdis.2024.107556 (PMID 38184971) — Singapore case report, PDLLA to nasolabial folds and infraorbital area https://doi.org/10.1016/j.jstrokecerebrovasdis.2024.107556
- Narins RS, et al. A randomized study of the efficacy and safety of injectable poly-L-lactic acid versus human-based collagen implant in the treatment of nasolabial fold wrinkles. J Am Acad Dermatol. 2010;62(3):448–62. doi:10.1016/j.jaad.2009.07.040 (PMID 20159311) — Randomised, 233 patients, nasolabial folds; effect to 25 months https://doi.org/10.1016/j.jaad.2009.07.040
- Firsowicz M, et al. Injectable Poly-l-Lactic Acid for Treatment of the Infraorbital Hollowing. Dermatol Surg. 2025;51(9S):S77–S80. doi:10.1097/DSS.0000000000004791 (PMID 40864851) — Retrospective, 28 patients, infraorbital hollowing https://doi.org/10.1097/DSS.0000000000004791
- Trinh LN, et al. Delayed Complications following Dermal Filler for Tear Trough Augmentation: A Systematic Review. Facial Plast Surg. 2022;38(3):250–259. doi:10.1055/s-0041-1736390 (PMID 34666405) — Delayed complications of tear-trough fillers, 52 cases https://doi.org/10.1055/s-0041-1736390
- Apikian M, et al. Adverse reactions to polylactic acid injections in the periorbital area. J Cosmet Dermatol. 2007;6(2):95–101. doi:10.1111/j.1473-2165.2007.00303.x (PMID 17524125) — Periorbital adverse reactions to PLLA https://doi.org/10.1111/j.1473-2165.2007.00303.x
- Stewart DB, et al. Management of visible granulomas following periorbital injection of poly-L-lactic Acid. Ophthalmic Plast Reconstr Surg. 2007;23(4):298–301. doi:10.1097/IOP.0b013e318070d773 (PMID 17667102) — Visible periorbital granulomas after PLLA https://doi.org/10.1097/IOP.0b013e318070d773
- Lowe NJ, et al. Injectable poly-l-lactic acid: 3 years of aesthetic experience. Dermatol Surg. 2009;35 Suppl 1:344–9. doi:10.1111/j.1524-4725.2008.01061.x (PMID 19207324) — Retrospective survey, 221 patients; advises avoiding perioral and periorbital areas https://doi.org/10.1111/j.1524-4725.2008.01061.x
- Roberts SA, et al. Severe visual loss and orbital infarction following periorbital aesthetic poly-(L)-lactic acid (PLLA) injection. Ophthalmic Plast Reconstr Surg. 2012;28(3):e68–70. doi:10.1097/IOP.0b013e3182288e4d (PMID 21862947) — Visual loss after periorbital PLLA https://doi.org/10.1097/IOP.0b013e3182288e4d
- Young SM, et al. Visual Loss in Biostimulator Injectables: A Review of Incidence, Risk Factors, Etiology and Management Proposal. Aesthetic Plast Surg. 2026;50(5):1994–2005. doi:10.1007/s00266-025-05418-2 (PMID 41263987) — Review of visual loss after biostimulators https://doi.org/10.1007/s00266-025-05418-2
- Su CY, et al. Comparative Physicochemical Characterization of Polylactic Acid-Based Dermal Fillers. Polymers (Basel). 2025;18(1):84. doi:10.3390/polym18010084 (PMID 41516868) — Particle shape and size of Sculptra and Juvelook https://doi.org/10.3390/polym18010084
- Nikolis A, et al. A Randomized Controlled Trial Evaluating Traditional Versus Extended Techniques of Poly- l -Lactic Acid Injection for the Aesthetic Improvement of the Temporal Fossae. Dermatol Surg. 2025;51(7):702–709. doi:10.1097/DSS.0000000000004569 (PMID 39964077) — Randomised, 24 patients, temple techniques, Sculptra https://doi.org/10.1097/DSS.0000000000004569
- Chang G, et al. Efficacy and Safety of a Poly-L-Lactic Acid Filler for Temporal Augmentation: A Randomized, No-treatment Control, Evaluator-blinded, Multicenter Study. Aesthet Surg J. 2026;46(6):652–662. doi:10.1093/asj/sjag013 (PMID 41637104) — Randomised controlled, 174 patients, temples; non-Sculptra PLLA https://doi.org/10.1093/asj/sjag013
- Signori R, et al. Efficacy and Safety of Poly-l-Lactic Acid in Facial Aesthetics: A Systematic Review. Polymers (Basel). 2024;16(18):2564. doi:10.3390/polym16182564 (PMID 39339028) — Systematic review of 11 RCTs; low-quality evidence https://doi.org/10.3390/polym16182564
- US FDA. Premarket approval P030050 and supplements S002 (2009), S034 (2021), S039 (cheek wrinkles, 25 April 2023); Sculptra labelling: periorbital injection not studied https://www.accessdata.fda.gov/cdrh_docs/pdf3/P030050S039C.pdf
- Galderma. Sculptra Instructions for Use, Australia, August 2026 — “Do not inject … in the periorbital area” https://www.galderma.com/sites/default/files/2026-09/Sculptra%20IFU_AU_August%202026.pdf
- Health Sciences Authority, Singapore Medical Device Register: Q-Med Sculptra, DE0006297; Vaim Juvelook, DE0507634; Vaim Lenisna 200, DE0507633 (data.gov.sg download, April 2026 listing) https://data.gov.sg/datasets/d_e697cc1e4caec596c0e9318fdd9420a3/view
- Sculptra price: Bay Aesthetics Clinic — PLLA first vial (10 ml) S$988 nett; à la carte S$1,308; package of 4 vials S$1,199 per vial (checked 2026-10-08) https://www.bayclinic.sg/treatment/sculptra-singapore/
- Sculptra price: Sozo Aesthetic Clinic — PLLA from S$1,000, depending on vials (checked 2026-10-08) https://sozoclinic.sg/fillers/plla-collagen-stimulator/
- Sculptra price: Become Aesthetics — PLLA collagen biostimulator S$3,000 nett (checked 2026-10-08) https://www.becomeaesthetics.com.sg/sculptra/
- Sculptra price: V Aesthetics Clinic — PLLA biostimulator S$3,000 per syringe (checked 2026-10-05) https://www.vaestheticsclinic.com.sg/price-list/
- Juvelook Volume price: Bay Aesthetics Clinic — Lenisna 1 vial S$988 nett (checked 2026-10-08) https://www.bayclinic.sg/juvelook-and-lenisna-juvelook-volume-price-in-singapore/
- Juvelook Volume price: Fundamental Aesthetic Clinic — from S$1,188 nett (checked 2026-10-08) https://www.fundamentalaestheticclinic.com.sg/lenisna-juvelook-volume-singapore
- Juvelook price: Bay Aesthetics Clinic — S$388 nett (JuveLook 3 ml); S$988 nett (full vial plus 2 ml HA booster) (checked 2026-10-08) https://www.bayclinic.sg/juvelook-and-lenisna-juvelook-volume-price-in-singapore/
- Juvelook price: Nueva Clinic — from S$688 per session (checked 2026-10-05) https://nuevaclinic.sg/treatment/juvelook/
- Juvelook price: V Medical Aesthetics — PDLLA Skin Booster S$1,200 nett (checked 2026-10-08) https://www.vaestheticsclinic.com.sg/juvelook/
- Juvelook price: Halley Medical Aesthetics — S$980 (PDLLA Skin Booster 2 ml) (checked 2026-10-05) https://www.halley.com.sg/price-list/
- Juvelook price: BA Clinic — S$950 per 2 ml (PDLLA skin booster) (checked 2026-10-05) https://baclinic.sg/treatments/skinbooster/

